Free Trial

CME Group Inc. (NASDAQ:CME) Shares Sold by Fmr LLC

CME Group logo with Finance background
Remove Ads

FMR LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 10.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 988,631 shares of the financial services provider's stock after selling 119,729 shares during the period. FMR LLC owned about 0.27% of CME Group worth $229,590,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of CME Group in the 4th quarter valued at $1,107,389,000. Raymond James Financial Inc. purchased a new position in CME Group in the fourth quarter valued at $871,063,000. Franklin Resources Inc. raised its stake in CME Group by 70.4% in the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider's stock valued at $544,157,000 after buying an additional 1,003,119 shares in the last quarter. Capital Wealth Planning LLC raised its stake in CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock valued at $565,671,000 after buying an additional 996,498 shares in the last quarter. Finally, Egerton Capital UK LLP purchased a new stake in CME Group during the 4th quarter worth about $223,967,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Analyst Ratings Changes

CME has been the topic of a number of recent analyst reports. Bank of America increased their price objective on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Oppenheimer increased their price target on shares of CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday. Piper Sandler boosted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price on the stock in a research report on Monday, March 10th. Finally, Morgan Stanley upgraded shares of CME Group from an "equal weight" rating to an "overweight" rating and set a $301.00 price target on the stock in a research note on Tuesday, April 8th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus target price of $247.47.

Remove Ads

Get Our Latest Stock Report on CME

CME Group Stock Performance

Shares of NASDAQ:CME traded down $0.82 during trading on Tuesday, reaching $262.87. The company had a trading volume of 1,567,580 shares, compared to its average volume of 2,137,529. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $273.42. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock's fifty day moving average price is $255.66 and its 200 day moving average price is $239.56. The firm has a market capitalization of $94.73 billion, a price-to-earnings ratio of 27.18, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a dividend of $1.25 per share. This is a boost from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.90%. The ex-dividend date of this dividend was Friday, March 7th. CME Group's dividend payout ratio is currently 51.71%.

Insider Activity at CME Group

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares in the company, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock worth $6,871,496 over the last 90 days. Company insiders own 0.30% of the company's stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads